Physician

Aaron William Pickens, MD

According to 2025 Medicare claims, Aaron Pickens, MD (NPI: 1821484650) practices pulmonary disease in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Davidson, NC. This provider's primary affiliated billing organization is WAKE FOREST UNIVERSITY HEALTH SCIENCES (NPI: 1003803032; TIN: 223849199) and primary practice location at 27157-0001. Pickens is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Pickens' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 231 traditional Medicare patients, billed 493 HCPCS/CPT codes, and received $28,757 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 757 prescription claims across 116 beneficiaries totaling $301,882 in drug costs, led by Stiolto Respimat (Tiotropium Br/Olodaterol Hcl). DME data shows 193 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,292 to $301,882. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	88	225	$21,398
2022	180	464	$38,246
2023	204	482	$36,145
2024	231	493	$28,757

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	56	$4,292
2017	N/R	32	$2,465
2018	N/R	26	$546
2019	N/R	N/R	N/R
2020	29	105	$21,832
2021	46	191	$57,192
2022	84	351	$183,607
2023	94	580	$377,683
2024	116	757	$301,882

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	31	$2,234
2023	N/R	104	$5,954
2024	N/R	193	$21,483

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	36	67	$152
94726	Test to determine lung volumes using sensors	50	50	$8
94060	Test to measure expiratory airflow and volume changes before and after medication administration	52	53	$8
94729	Test to examine how well the lungs exchange gases	68	68	$6
94010	Test to measure expiratory airflow and volume	44	44	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	137	4,404	$69,910
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	1,260	$27,124
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	57	1,710	$24,276
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	29	930	$19,975
Spiriva Respimat	Tiotropium Bromide	34	1,080	$19,198

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	16	$12,188
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	34	$2,979
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	15	$2,151
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	29	$1,552
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	40	$957

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Aaron William Pickens, MD?

Tedicare shows public-source Medicare data for Aaron William Pickens, MD (NPI 1821484650), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron William Pickens, MD have ACO affiliation data?

Aaron William Pickens, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Aaron William Pickens, MD?

Aaron William Pickens, MD is linked to WAKE FOREST UNIVERSITY HEALTH SCIENCES (billing NPI 1003803032) in the available physician profile data.

Does Aaron William Pickens, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.